Press Release

Global Oral Cancer Treatment Market to grow with a CAGR of 5.20 %

Increasing healthcare infrastructure and a supportive regulatory environment are the major drivers for the Global Oral Cancer Treatment Market.

According to TechSci Research report, “Global Oral Cancer Treatment Market Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028”, Global Oral Cancer Treatment Market has valued at USD 2.01 billion in 2022 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 5.20% through 2028.  This can be due to collaborations and partnerships among leading companies with a diverse approach to merge the expertise of individual companies and to strengthen their position in the market.

Innovations in imaging and diagnostic technologies have played a significant role in driving the demand for oral cancer treatment. Advanced imaging technologies, such as cone beam computed tomography (CBCT) and optical coherence tomography (OCT), allow for the early detection of oral cancer and precancerous lesions. Early diagnosis is essential for effective treatment and improved outcomes, which in turn increases the demand for treatment. High-resolution imaging technologies provide more accurate and detailed information about the location and extent of tumors. This precision is crucial in surgical planning and the determination of treatment modalities, leading to better outcomes. Advanced imaging allows for a better understanding of the unique characteristics of each patient's cancer. This information can guide the development of personalized treatment plans, enhancing the demand for tailored therapies. Three-dimensional imaging and diagnostic tools help in the planning of radiation therapy and surgery. They enable healthcare professionals to precisely target the tumor while sparing healthy tissue, reducing side effects and the need for extensive treatment. Real-time imaging during surgery can aid surgeons in ensuring complete tumor removal while minimizing damage to surrounding structures. This is particularly important in complex oral cancer surgeries.

 

Browse over XX market data Figures and spread through XX Pages and an in-depth TOC on " Global Oral Cancer Treatment Market

 

In September 2023, Viome Life Sciences, a prominent company dedicated to preventive health technology, has introduced Oral Health Pro with Cancer Detect, a revolutionary test that is poised to transform the dental industry's approach to oral care. This innovative test offers dental professionals an unprecedented level of actionable insights into their patients' health. By leveraging Viome's proprietary RNA sequencing technology and artificial intelligence (AI), Oral Health Pro with Cancer Detect measures the gene expression of both the oral microbiome and human cells in a patient's saliva. This enables the early detection of biomarkers associated with oral and throat cancer, leading to potentially life-saving interventions. The significance of this test is underscored by the FDA's designation of the underlying Cancer Detect technology as a Breakthrough Device, ensuring an accelerated review process. Oral Health Pro is not only reshaping how dental professionals and individuals view oral health but also emphasizing the profound connection between oral well-being and overall bodily health. The test can identify a wide range of biomarkers related to conditions such as gum health, cavities, halitosis, pathobiont activity, fungal activity, and genotoxic activity, many of which have implications for systemic health.

Treatment costs are a significant challenge in the global oral cancer treatment market. The financial burden associated with oral cancer treatment can be substantial, and it affects various stakeholders, including patients, healthcare systems, and governments. Oral cancer treatment often involves multiple modalities, including surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy. These treatments can be costly, particularly when they are administered in combination or over extended periods. Following oral cancer treatment, patients may require dental rehabilitation to restore oral function and aesthetics. This may involve procedures such as dental implants, dentures, and other dental prostheses, which can add to the overall cost. Chemotherapy drugs, targeted therapies, and immunotherapies can be expensive. Some of these drugs need to be administered over an extended period, contributing to the financial burden. Advanced imaging and diagnostic tests play a crucial role in the diagnosis and monitoring of oral cancer. These tests, such as PET-CT scans and MRI, can be expensive. Long-term follow-up care and surveillance are necessary to monitor disease recurrence and manage late-onset side effects. These ongoing medical expenses can add to the overall treatment costs.

Global Oral Cancer Treatment Market is segmented based on Type, Treatment, Distribution Channel, and by region.

Based on the Type, Global Oral Cancer Treatment Market is segmented Squamous Cell Carcinoma, Verrucous Carcinoma, Minor Salivary Gland Carcinomas, Lymphomas, others. Minor salivary gland carcinomas are a group of malignant tumors that originate in the minor salivary glands, which are located throughout the oral cavity and other parts of the head and neck. These glands are distinct from the major salivary glands (such as the parotid, submandibular, and sublingual glands) and are responsible for producing saliva to keep the mouth moist and aid in digestion. Minor salivary gland carcinomas are relatively rare compared to other types of oral cancer. However, they are diverse in terms of their location and histological subtypes, meaning they can occur in various areas of the head and neck, each with distinct characteristics. There are several histological subtypes of minor salivary gland carcinomas, each with its unique characteristics. Common subtypes include mucoepidermoid carcinoma, adenoid cystic carcinoma, adenocarcinoma, polymorphous low-grade adenocarcinoma, and acinic cell carcinoma.

Based on Region, North America held the largest share in the Global Oral Cancer Treatment Market. North America has been a significant location for clinical trials related to cancer treatment, including oral cancer. This participation in research helps advance the understanding of disease and the development of new treatment options. Patients in North America generally have greater awareness of the importance of cancer screening, including oral cancer. This awareness leads to higher rates of early detection and diagnosis. The relatively high economic status of many individuals in North America allows them to seek and afford advanced treatments and therapies, contributing to the growth of the oral cancer treatment market. The region has a robust network of dental and medical professionals who collaborate to provide comprehensive care, including oral cancer treatment.

Some of the major companies operating in the Global Oral Cancer Treatment Market include:

  • Novartis AG
  • Hospira, Inc.
  • Teva Pharmaceutical Industries Ltd
  • Pfizer Inc.
  • Lilly USA, LLC
  • Merck & Co., Inc.
  • Fresenius Kabi AG
  • Accord BioPharma, Inc.
  • Bristol-Myers Squibb Company
  • Spectrum Pharmaceuticals, Inc.

 

Download Free Sample Report

Customers can also request for 10% free customization on this report


“Certain areas, particularly in North America, are projected to exert significant demand for Oral Cancer Treatment. The growth in the competitive landscape and the presence of well-established companies in the market, committed to enhance the overall wellbeing of people each year, are expected to contribute to a remarkable growth of the Global Oral Cancer Treatment Market in the forecast period," said Mr. Karan Chechi, Research Director with TechSci Research, a research-based Global management consulting firm.

"Global Oral Cancer Treatment Market by Type (Squamous Cell Carcinoma, Verrucous Carcinoma, Minor Salivary Gland Carcinomas, Lymphomas, others), by Treatment (Targeted Therapy, Chemotherapy, Immunotherapy), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, By Competition Forecast & Opportunities, 2018-2028F" has evaluated the future growth potential of Global Oral Cancer Treatment Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide innovative market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Oral Cancer Treatment Market.


Contact

Techsci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +13322586602

Email: [email protected]               

Website: www.techsciresearch.com

Relevant News